Ampio Pharmaceuticals appoints Gregory A. Gould CFO
Ampio Pharmaceuticals has appointed Gregory A. Gould chief financial officer, treasurer and corporate secretary. Gould, a veteran of the pharmaceutical and life sciences industry, is joining the company effective June 10. Mark McGregor, the company's current chief financial officer, will retire from Ampio Pharmaceuticals following a transition period later this year.
Gould has over eighteen years of senior management experience at public pharmaceutical and life sciences companies, where he has demonstrated success leading accounting and finance organizations, inclusive of fundraising, licensing transactions and acquisitions.
Most recently, Gould was the interim president and chief executive officer and chief financial officer of SeraCare Life Sciences, in Milford, Mass. Previously, Gould was the chief financial officer of Atrix Laboratories, in Fort Collins, Colo. Gould held positions of increasing responsibility in finance and accounting at Colorado MedTech in Boulder, Colo., a publicly traded medical device design and manufacturing company. Gould currently serves on the board of directors of CytoDyn, a publicly traded drug development company pursuing ant-viral agents for the treatment of HIV.